Note:
We update this information every month.
Note:
Here we use data from Rhode Island Department of Health (RIDOH), Substance Abuse and Mental Health Services Administration (SAMHSA), and Rhode Island Dept of Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH).
The number of Rhode Islanders on medication assisted treatment (MAT) is on the rise
Buprenorphine/naloxone, naltrexone, and methadone are evidence-based treatments for opioid addiction (also called opioid use disorder). A key initiative under the Governor’s action plan is to increase the number of people accessing medication assisted treatment (MAT). Learn more about our action plan to address addiction and overdose in Rhode Island.
Number of Patients Actively Receiving Methadone
Note: Data updated monthly
Number of Patients Actively Receiving Buprenorphine
Note: Data updated monthly
Note: Buprenorphine data includes people prescribed buprenorphine through the Prescription Drug Monitoring Program (PDMP), as well as people who are dispensed buprenorphine at a Center of Excellence (COE) or at the Rhode Island Department of Corrections.
Note: Data for June, July, and Augusut of 2018 does not include buprenorphine from Centers of Excellence (COEs)
Number of Patients Actively Receiving VIVITROL
Note: Data updated quarterly
Medication assisted treatment options are available throughout Rhode Island
Find a treatment provider in your community on our Find Treatment page.
Number of Waivered Providers Able to Prescribe Buprenorphine, Number of Opioid Treatment Programs for Methadone Therapy by City/Town, and Number of VIVITROL Providers by City/Town
Note: Data updated yearly